ARCHIVES

Hudis’s Address At ASCO 2014: On Value & Commitment

This article is from The Cancer Letter archive.

Vol. 40 No. 23 | June 6, 2014

Download PDF Visit The Full Archive

Related Articles

Phase II Elotuzumab Study Demonstrates 33 Months PFS

July 26, 2013

Max Wicha Describes Michigan’s Restructuring Planning For Growth

May 7, 1999

Duke University Suspends Two Clinical Trials After Journal Paper Questions Assay Validity

October 9, 2009

Hope for FDA authority over tobacco products dies in Congress.

October 15, 2004

Cancer & The Media: Klausner, Watson Dispute Comments In New York Times Story

May 8, 1998

Funding opportunities listed.

February 6, 2004